ATG2B and metabolic dysfunction-associated steatotic liver disease: Ginsenoside Rg1 exerts its effects on autophagy and pyroptosis by modulating the miR-375–3p/ATG2B/PTEN-AKT pathway, thereby mitigating the pathogenesis and progression of NAFLD.